Pharmacogenomic (PGx) testing is a rapidly advancing area of precision medicine that offers key insights into how genetic variation impacts patient medication response. This live educational webinar covers core concepts in pharmacogenomics, exploring clinical evidence, practice guidelines, and practical tools to help physicians optimize treatment safety and efficacy.
Webinar Details
- Date: Wednesday, September 16, 2026
- Time: 12:00 – 1:00 pm
- Format: Live virtual via Zoom
- CME Credit: Earn up to 1 AMA PRA Category 1 Credit(s)™
Learning Objectives
During this activity, participants will:
- Discuss fundamental genetic principles relevant to PGx testing and results interpretation.
- Evaluate how genetic variation influences drug metabolism, therapeutic efficacy, and adverse-event risks.
- Utilize trusted PGx resources, including CPIC guidelines and FDA drug-labeling information, to inform prescribing decisions.
- Analyze real-world patient cases to seamlessly integrate PGx evidence into everyday clinical workflows.
Featured Presenter
Josiah Allen, PharmD, Pharmacogenomics Pharmacist & PGY2 Residency Program Director, St. Elizabeth Healthcare, Adjunct Assistant Professor, Department of Experimental and Clinical Pharmacology, University of Minnesota
Registration and Support
Physicians and healthcare professionals across all specialties are invited to join.
Need assistance? Contact the MSMS Education team at 517-336-5790 or educationdept@msms.org.
Statement of Accreditation
The Michigan State Medical Society (MSMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The MSMS designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.